BIOSTAGE
Biostage is a pioneering biotechnology company in the emerging field of regenerative medicine. Their goal is to regenerate and restore organ function of the esophagus, trachea, or bronchus damaged by cancer, trauma, infection, or congenital diseases. The company’s novel Cellframe technology is engineered to stimulate the body’s signaling pathways and natural healing process to regenerate and restore organ function. Our Cellframe technology is based on over 20 years of scientific progress in the fields of tissue engineering, cell biology, and material science. Cellframe technology combines the best attributes of a synthetic scaffold with tissue engineering and cell biology to create what may be a revolutionary method of addressing organ damage.
BIOSTAGE
Industry:
Biotechnology Health Care Medical Device
Founded:
2012-05-03
Address:
Holliston, Massachusetts, United States
Country:
United States
Website Url:
http://www.biostage.com
Total Employee:
11+
Status:
Active
Contact:
+117742337300
Email Addresses:
[email protected]
Total Funding:
24.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Font Awesome IPv6 ReCAPTCHA Cloudflare Cloudflare Hosting Cloudflare SSL ReCAPTCHA V2
Similar Organizations
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Gelesis
Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients.
Vero Biotech
Vero Biotech is a biopharmaceutical company that commercializes inhaled nitric oxide delivery systems for healthcare providers.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Connecticut Children’s Medical Center
Connecticut Children’s Medical Center investment in Post-IPO Equity - Biostage
Bin Zhao
Bin Zhao investment in Post-IPO Equity - Biostage
Key Employee Changes
| Date | New article |
|---|---|
| 2022-08-08 | Biostage Announces Appointment of New Chief Financial Officer |
| 2022-01-25 | Biostage Announces "Meet the Founder, New Chairman and Interim CEO" Webinar |
| 2021-11-30 | Biostage Hires David Green as Chief Executive Officer |
Official Site Inspections
http://www.biostage.com Semrush global rank: 5.73 M Semrush visits lastest month: 1.46 K
- Host name: 104.21.34.189
- IP address: 104.21.34.189
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Biostage"
Biostage Company Profile - Office Locations, Competitors, …
Sep 20, 2023 Biostage has 5 employees at their 1 location and $103 k in annual revenue in FY 2023. See insights on Biostage including office locations, competitors, revenue, financials, …See details»
Hregen
Biostage, Inc. Changes Name to Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN)See details»
Harvard Apparatus Regenerative Technology - Crunchbase
Biostage is a biotechnology company developing esophageal implants for patients battling life-threatening conditions. It uses the patient’s stem cells grown on a porous plastic tubular …See details»
Biostage - Org Chart, Teams, Culture & Jobs | The Org
View Biostage's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Biostage, Inc. Changes Name to Harvard Apparatus Regenerative ...
Jul 20, 2023 About Biostage We are a clinical-stage biotechnology company developing regenerative-medicine treatments for disorders of the gastro-intestinal system and the airway …See details»
Biostage Company Profile 2024: Stock Performance & Earnings
Information on stock, financials, earnings, subsidiaries, investors, and executives for Biostage. Use the PitchBook Platform to explore the full profile.See details»
Biostage - Corporate Governance
{loadmoduleid 161} . Corporate Governance The Board’s duty is to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business. To fulfill these …See details»
Biostage, Inc. Changes Name to Harvard Apparatus Regenerative …
Jul 20, 2023 --Biostage, Inc. announced today it has changed its corporate name back to Harvard Apparatus Regenerative Technology, Inc. and will trade under the OTCQB symbol …See details»
Company Biostage, Inc. Nasdaq - MarketScreener.com
Biostage, Inc.: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nasdaq: BSTG | NasdaqSee details»
Biostage - Overview, News & Similar companies | ZoomInfo.com
Jul 19, 2023 View Biostage (www.biostage.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Biostage - VentureRadar
"Biostage is a preclinical biotechnology company focused on tissue engineering and the production of combination products designed to restore function of the GI tract following …See details»
Biostage, Inc | Ocean 海外华人企业家联合会
Ocean - Oversea Chines-American Entrepreneur Association, 海外华人企业家联合会, is an officially registered in 1999 as non-political, non-religion and non-profit organization, …See details»
Biostage, Inc. Changes Name to Harvard Apparatus ... - BioSpace
Jul 20, 2023 Biostage, Inc. (OTCQB: formerly BSTG) announced today it has changed its corporate name back to Harvard Apparatus Regenerative Technology, Inc. and trade under …See details»
Biostage Initiated Study Start-up Activities for Clinical Trial in ...
May 31, 2023 About Biostage. We are a clinical-stage biotechnology company developing regenerative-medicine treatments for disorders of the gastro-intestinal system and the airway …See details»
Biostage Announces Chairman and CEO Transition - BioSpace
Mar 2, 2023 Biostage Announces Chairman and CEO Transition - read this article along with other careers information, tips and advice on BioSpaceSee details»
Inside Scoop on Biostage, a World Leader in Bioengineered Organs
Oct 30, 2017 Biostage is a clinical-stage company specializing in bioengineered organ implants to treat cancer and conditions involving the esophagus, bronchus and trachea.See details»
Biostage Reports Corporate Highlights and Second Quarter …
Aug 4, 2022 Biostage is a clinical-stage biotech company that uses cell therapy to regenerate organs inside the human body to treat cancer, trauma and birth defects in the esophagus and …See details»
Biostage Announces $6 Million Financing to Advance Clinical
Apr 6, 2023 About Biostage We are a clinical-stage biotechnology company developing regenerative-medicine treatments for disorders of the gastro-intestinal system and the airway …See details»
Biostage Announces $5.1 Million Financing to Advance Clinical Trial
May 13, 2022 About Biostage. Biostage is a clinical-stage biotech company that uses cell therapy to regenerate organs inside the human body to treat cancer, trauma and birth defects.See details»
Biostage Selects IQVIA to Manage its FDA-Approved Clinical
Dec 28, 2022 Biostage has 12 issued U.S. patents and 2 orphan-drug designations which can provide seven years of market exclusivity in addition to any exclusivity granted by patents. …See details»